TIME COURSE OF CHANGES IN THE LEVEL OF C-TERMINAL TELOPEPTIDES DURING THERAPY IN PATIENTS WITH OSTEOARTHRITIS

Download full text PDF
Issue: 
5
Year: 
2016

Professor O. Maiko, MD; E. Savelova, Candidate of Medical Sciences Orenburg State Medical University

The level of C-terminal telopeptides arising from collagen type II degradation during 3-month therapy using chondroitin sulfate (Structum), its combination with glucosamine hydrochloride (Artra) and Zeel T was estimated in patients with osteoarthritis. Better values were observed in gonarthrosis, particularly when Artra was used at the early stages of the disease; worse values were seen in Stage III osteoarthritis and its duration > 10 years.
Keywords: 
osteoarthritis
chondroitin sulfate
glucosamine hydrochloride
Zeel T
C-terminal telopeptides arising from collagen type II

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Alekseeva L.I., Chichasova N.V., Mendel' O.I. Ratsional'nyj vybor bazisnoj terapii pri osteoartroze. Rezul'taty otkrytogo randomizirovan-nogo mnogotsentrovogo issledovanija preparata ARTRA® v Rossii // RMZh. – 2005; 13 (24): 1637–41.
  2. Karateev A.E. Gastroduodenal'naja bezopasnost' selektivnyh ingibito rov tsiklooksigenazy-2: proverka praktikoj // Ter. arh. – 2005; 5: 69–72.
  3. Karateev A.E., Alekseeva L.I., Bratygina E.A. Otsenka chastoty razvitija pobochnyh effektov pri dlitel'nom primenenii nimesulida v real'noj klinicheskoj praktike // RMZh. – 2009; 17 (21): 1466–72.
  4. Majko O.Ju. Kliniko-ekonomicheskie aspekty primenenija nestero idnyh protivovospalitel'nyh i modifitsirujuschih strukturu hrjascha sredstv pri osteoartroze. Avtoref. dis. … d-ra med. nauk. Orenburg, 2008; 43 s.
  5. Nasonova V.A., Alekseeva L.I., Arhangel'skaja G.S. i dr. Itogi mnogo tsentrovogo klinicheskogo issledovanija preparata struktum v Rossii // Ter. arh. – 2001; 11: 84–7.
  6. Nasonova V.A. Osteoartroz: problema polimorbidnosti // Consilium 6. Medicum. – 2009; 11 (2): 234–45.
  7. Shtresser V., Vajzer M. Gomeopaticheskoe lechenie gonartroza: rezul'taty dvojnogo slepogo issledovanija // Biol. meditsina. – 2001; 2: 21–6.
  8. Erdes Sh.F., Folomeeva O.M. Revmaticheskie zabolevanija i invalid nost' vzroslogo naselenija Rossijskoj Federatsii // Nauchno-prakticheskaja revmatol. – 2007; 4: 4–9.
  9. Christgan S., Henrotin Y., Tanko L. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate // Clin. Exp. Rheumatol. – 2004; 22 (1): 36–42.
  10. Ishijima M., Watari T., Naito K. et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis // Arthritis Research & Therapy. – 2011; 13 (1): 2.
  11. Jung M. Elevated urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis // Pathobiology. – 2004; 71 (2): 70–6.
  12. Hochberg M. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration // Osteoarthritis Cartilage. – 2010; 18 (1): 28–31.
  13. Garnero P., Charni N., Juillet F. et al. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis // Ann. Rheum. Dis. – 2006; 65: 1639–44.
  14. Gineyts E., Mo J., Ko A. et. al. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis // Ann. Rheum. Dis. – 2004; 63: 857–61.
  15. Kahan A., Uebelhart D. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial // Arthr. Rheum. – 2009; 60: 524–33.
  16. Manicourt D., Bevilacqua M., Righini V. et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis // Drugs R.D. – 2005; 6: 261–71.
  17. Mazzuca S., Brandt K., Eyre D. et al. Urinary levels of type II collagen c-telopeptide crosslinks are unrelated to joint space narrowing in patients with knee osteoarthritis // Ann. Rheum. Dis. – 2006; 65: 1055–9.
  18. Marrona U., Weiser M., Klein P. Orale Behandlung der Gonarthrose mit Zeel compositum // Orthop. Praxis. – 2000; 5: 285–91
  19. Oestergaard S., Chouinard L., Doyle N. et al. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis // Arthr. Rheum. – 2006; 54: 2886–90
  20. Rozendaal R., Uitterlinden E. et al. Glucosamine sulphate effects on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial // Osteoarthritis Cartilage. – 2009; 17: 427–32.
  21. Reijman M., Hazes J., Bierma-Zeinstra S. A new marker for osteoarthritis: 21. cross-sectional and longitudinal approach // Arthr. Rheum. – 2004; 50; 2471–8.
  22. Sharif M., Kirwan J., Charni N. et al. A 5-yr longitudinal study of type IIA 22. collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression // Rheumatology. – 2007; 46: 938–43.
  23. Zhang W., Nuki G., Moskowitz R. et al. OARSI recommendations for the 23. management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009 // Osteoarthritis Cartilage. – 2010; 18: 476–99.